Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 2/3 1Phase 1/2 1

Status

Recruiting 3Active not recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Lymphoid 5Other hematologic neoplasm 4Myeloid 1

Conditions

Leukemia, Myeloid, Acute 23Precursor Cell Lymphoblastic Leukemia-Lymphoma 18Leukemia 17Myelodysplastic Syndromes 14Primary Myelofibrosis 10Leukemia, Myelogenous, Chronic, BCR-ABL Positive 10Myeloproliferative Disorders 9Leukemia, Myelomonocytic, Chronic 8Leukemia, Lymphocytic, Chronic, B-Cell 6Hematologic Neoplasms 6Graft vs Host Disease 6Myelodysplastic-Myeloproliferative Diseases 5Leukemia, Myeloid, Chronic-Phase 5Thrombocythemia, Essential 4Recurrence 4Polycythemia Vera 4Neoplasms 4Multiple Myeloma 4Lymphoma 4Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 4Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3Lymphoma, T-Cell 3Leukemia, Prolymphocytic, T-Cell 3Prostatic Neoplasms 2Pancreatic Neoplasms 2Lymphoma, T-Cell, Cutaneous 2Lymphoma, Non-Hodgkin 2Leukemia, Myeloid, Accelerated Phase 2Leukemia, Monocytic, Acute 2Leukemia, Large Granular Lymphocytic 2

Interventions

Cyclophosphamide 72Cytarabine 61fludarabine phosphate 48venetoclax 42Peripheral Blood Stem Cell Transplantation 37fludarabine 34Busulfan 31Methotrexate 29Cyclosporine 29Mycophenolic Acid 28Filgrastim 27Azacitidine 27Antilymphocyte Serum 26Whole-Body Irradiation 22Etoposide 21Radiotherapy 20Melphalan 20Tacrolimus 19Rituximab 19Dexamethasone 16Methylprednisolone 15Granulocyte Colony-Stimulating Factor 15Decitabine 15Vincristine 14Cord Blood Stem Cell Transplantation 14Doxorubicin 13Clofarabine 11Mitoxantrone 10ibrutinib 9blinatumomab 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Recurrence × ruxolitinib × Other hematologic neoplasm × Clear all
NCT05010005 2026-04-09

A Study of Ruxolitinib and Duvelisib in People With Lymphoma

Memorial Sloan Kettering Cancer Center

Phase 1 Recruiting
70 enrolled
LymphoidOther hematologic neoplasm

Recurrence, Leukemia, Prolymphocytic, T-Cell, Lymphoma, T-Cell, Leukemia, Large Granular Lymphocytic

NCT07366801 2026-01-26

Co-infusion of Treg-enriched Donor Lymphocytes With CD3-depleted Hematopoietic Stem Cell Graft to Prevent Graft-versus Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation Among Children With Hematologic Malignancies

Federal Research Institute of Pediatric Hematology, Oncology and Immunology

Phase 2/3 Recruiting
64 enrolled
LymphoidOther hematologic neoplasm

Recurrence, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT06768476 2026-01-16

AML

University of Pennsylvania

Phase 1 Active not recruiting
12 enrolled
Other hematologic neoplasm

Leukemia, Recurrence, Leukemia, Myeloid, Acute

NCT05745714 2025-09-16

HEM-iSMART C

Princess Maxima Center for Pediatric Oncology

Phase 1/2 Recruiting
26 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Recurrence, Precursor B-Cell Lymphoblastic Leukemia-Lymphoma, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡